👁️GURU.Markets👁️

🛒 tuku 1 000

🌙

☀️

ENTX Total Utang marang Modal Entera Bio

Entera Bio Ltd. (ENTX) develops tablet alternatives to injections, ensuring global reach with low production costs. The business moat is based on ProNeura platform patents and user-friendly software that shuts out competitors. Logistics optimization through the elimination of cold chain requirements enhances margins. The company's price evolution with the 0.06 indicator is illustrated below.

ENTX: Total Utang marang Modal Entera Bio Corp 04.07.2022 - 28.10.2026

Rincian analitis lan laporan data perusahaan Entera Bio (ENTX)

- rega lan prakiraan konsensus rega:

Bagan rega Entera Bio Ltd|ENTX - Bagan tingkat prakiraan

- data kapitalisasi pasar:

Kapitalisasi pasar Entera Bio|ENTX - Nilai Dipunlarasaken Utang lan Kas

- data kapitalisasi buku:

Nilai Buku saben Saham Entera Bio|ENTX - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku enterabio.com|ENTX - Nilai Agregat Aset

- data utang lan likuiditas:

Utang marang Ekuitas Entera Bio Ltd.|ENTX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Entera Bio Ltd|ENTX - Gunggung utang perusahaan|Utang marang nilai buku Entera Bio|ENTX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Entera Bio

Analisis komprehensif perusahaan:ENTX - Entera Bio Ltd.

Produk merek Entera Bio

Entera Bio Ltd. (ENTX) specializes in the innovative development of oral formulations for injectable drugs, which entails high R&D risks. By analyzing the debt-to-equity chart, an investor assesses the balance between borrowed funds and equity, where excessive leverage increases debt service costs, while a lack thereof may limit the profitability and scaling pace of the pharmaceutical business.

Pesaing wigati

Utang marang Ekuitas Haleon HLN|Utang Agregat marang Ekuitas Kenvue Inc|Verona Pharma Corp (VRNA) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Jyong Bio (MENS)|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|amneal.com - Total Utang marang Modal|Utang marang Ekuitas Perrigo (PRGO)|ALVO: Rasio Kabeh Utang marang Dana Pribadi|LQDA (Liquidia Technologies) - Utang marang Ekuitas|Galapagos Corp (GLPG) - Rasio Total Utang marang Ekuitas|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com (MNKD)|Amphastar Pharmaceuticals, Inc. (AMPH) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PCRX (Pacira Pharmaceuticals)|SPRY: Utang marang Ekuitas|TBPH - Utang marang Modal|Rasio Total Utang marang Ekuitas Aquestive Therapeutics AQST|SCPH - Utang Agregat marang Modal|Total Utang marang Modal tectonictx.com TECX|Tonix Pharma (TNXP) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal SXTC (SXT Pharmaceuticals)|Utang marang Modal EPRX|BioHarvest Sciences (BHST) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi invizyne.com (EXOZ)|ORMP: Total Utang marang Modal|MindWalk Holdings, Inc. - Utang marang Modal|ABVC BioPharma Inc (ABVC) - Utang marang Ekuitas|Cumberland Corp (CPIX) - Rasio Utang marang Ekuitas|QNTM - Rasio Total Utang marang Ekuitas|fibrogen.com (FGEN) - Utang Agregat marang Modal|Total Utang marang Modal TELO (Telomir Pharmaceuticals, Inc.)|Utang marang Modal RANI|Synergy CHC Corp (SNYR) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi rallybio.com (RLYB)|Total Utang marang Modal LEXX (Lexaria Bioscience Corp.)|PULM - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Pheton (PTHL)|APM - Rasio Kabeh Utang marang Dana Pribadi|Lyra Therapeutics, Inc (LYRA) - Total Utang marang Modal|Impact BioMedical, Inc. (IBO) - Utang marang Ekuitas|TNFA: Total Utang marang Modal|Koefisien Total Utang marang Modal YCBD|PainReform - Utang marang Ekuitas|Utang marang Modal altamiratherapeutics.com CYTO|Rasio Total Utang marang Ekuitas Lipella|OptiNose Corp - Rasio Kabeh Utang marang Dana Pribadi|PIRS - Utang marang Ekuitas|procapsgroup.com (PROC) - Utang marang Ekuitas|PTPI - Rasio Total Utang marang Ekuitas|Qilian International Holding Group (QLI) - Utang Agregat marang Modal|Total Utang marang Modal ACELYRIN, Inc. (SLRN)|Rasio Utang marang Ekuitas TFF Pharmaceuticals, Inc (TFFP)